Okay, let's tackle this question about apo B48 and apo B100. The question is asking why these two apolipoproteins are expressed as different proteins. The options aren't provided, but I need to figure out the correct answer and explain it properly.

First, I remember that apolipoproteins are proteins that bind lipids to form lipoproteins. Apo B48 and apo B100 are both involved in lipid transport. Apo B100 is found in very low-density lipoproteins (VLDL) and low-density lipoproteins (LDL), while apo B48 is in chylomicrons.

Now, why are they different? I think it's related to RNA processing. There's something about a process called RNA editing where a specific nucleotide is changed. In the case of apo B, the mRNA for apo B100 is edited in the intestine to produce apo B48. This editing changes a codon from CAA (glutamine) to UAA (a stop codon), leading to a shorter protein. So, the difference is due to RNA editing, not a different gene.

The correct answer would be RNA editing. Let me check the options again. If the options include RNA editing, that's the right choice. The other options might be about gene duplication, alternative splicing, or different promoters. Gene duplication would create entirely different genes, but here it's the same gene with edited mRNA. Alternative splicing could create different isoforms, but in this case, it's RNA editing. Different promoters would lead to different expression levels but not structural differences.

So the key point is that apo B48 and apo B100 result from RNA editing of the same gene. The clinical pearl here is that this editing is crucial for the function of chylomicrons versus VLDL/LDL. Also, this process is catalyzed by an enzyme called ADAR (adenosine deaminase acting on RNA), which deaminates adenosine to inosine, changing the codon.

I need to make sure I explain why the other options are incorrect. For example, if an option says "different genes," that's wrong because they come from the same gene. If another option is "alternative splicing," that's incorrect because the difference is due to RNA editing, not splicing.

Putting it all together, the core concept is RNA editing leading to different apolipoprotein isoforms. The correct answer is RNA editing, and the explanation should highlight the specific mRNA modification in the apo B gene.

**Core Concept**
Apo B48 and apo B100 are isoforms of the apolipoprotein B gene (APOB) produced through **RNA editing** in the liver and intestine. This process involves adenosine-to-inosine (A-to-I) conversion in pre-mRNA, altering the coding sequence and resulting in distinct protein isoforms.

**Why the Correct Answer is Right**
The APOB gene undergoes **RNA editing** in intestinal epithelial cells, where an adenosine (A) in the mRNA is deaminated to inosine (I) by the enzyme ADAR. This converts the codon **CAA (glutamine)** to **UAA (a stop codon)**

✓ Correct Answer: A. RNA editing